Suchergebnisse - "Osborne, Vicki"

PubPharm (83)

1

Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry

enthalten in: Pharmacoepidemiology and drug safety | 2024

von Osborne, V. | Goodin, A. | Brown, J. | +12

2

Prescription Opioid Use Among a Community Sample of Older and Younger Women

enthalten in: Journal of women's health (2002) | 2022

von Serdarevic, M. | Osborne, V. | Striley, C. | +1

3

Postmarketing studies : can they provide a safety net for COVID-19 vaccines in the UK?

enthalten in: BMJ evidence-based medicine | 2022

von Dhanda, S. | Osborne, V. | Lynn, E. | +1

4

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

enthalten in: Drug safety | 2021

von Osborne, V. | Lane, S. | Shakir, S.

5

Opioids in the United Kingdom : safety and surveillance during COVID-19

enthalten in: Current opinion in psychiatry | 2021

von Osborne, V.

6

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

enthalten in: Drug safety | 2021

von Osborne, V. | Lane, S. | Shakir, S.

7

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

enthalten in: Drug safety | 2021

von Osborne, V. | Lane, S. | Shakir, S.

8

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

enthalten in: Drug safety | 2021

von Osborne, V. | Lane, S. | Shakir, S.

9

Remdesivir in treatment of COVID-19: A systematic benefit-risk assessment

enthalten in: bioRxiv.org | 2021

von Davies, M. | Osborne, V. | Lane, S. | +4

10

Lopinavir-Ritonavir in treatment of COVID-19: A dynamic systematic benefit-risk assessment

enthalten in: bioRxiv.org | 2021

von Osborne, V. | Davies, M. | Lane, S. | +5

1
2
3
4
5
6
7
8
9
Nächster »
[9]